In General

X2.0 will set up custom and needs based 5-month deeptech programme. The program will tailor its services to the needs of each startup, ensuring growth, scaling up, long term impact and cross border connections. Each selected startup will be screened by Venture Capital and Innovation experts and based on their insights, validated industry experts and their services will be proposed.

What are they looking for?

HealthTech & BioTech Call is open to all areas of both physical and mental health, including improvements to existing healthcare structures (human and veterinary) and all biotechnologies directly tied to service improvements and disease management. Startups that have innovative solutions including new diagnostics, devices, or therapy services to enable improved disease and infrastructure management, as well as the organization of care, are invited to apply.

More specifically, X2.0 is looking for HealthTech startups with solutions in the following: mobile health apps, electronic health and medical records, wearable devices (linked to health), telehealth and telemedicine, and management and IT software (linked to health). X2.0 is seeking startups that have a clear role in the areas of biopharmaceuticals, cell therapy, gene therapy and genome editing, antimicrobial resistance, pain and addiction, drug development, review and lifecycle management, rare diseases and orphan drugs, and vaccines and biodefense.

Why to participate / Benefits

Innovation Vouchers to cover

  • Needs-based growth and scaling services in the max. amount of €20,000
  • 1-on-1 mentorship with experts from the field of need in the min. amount of €5,000
  • Access large-scale startup and investor-oriented events, exhibitions, and fairs in the amount of €5,000

Other Program Benefits

  • Corporate Matchmaking and procurement
  • Private Fundraising assistance
  • Custom EU funding and public procurement ecosystem and overview
  • Talent Matchmaking & Job promotion
  • Promotion & Visibility

Key Dates

  • Open Call: Start date: 04.07.2023 / End Date: 05.09.2023
  • Evaluation: Start date: 06.09.2023 / End Date: 29.09.2023
  • Growth programme: Start date: 01.11.2023 / End Date: 31.03.2024
  • Evaluation: Start date: 06.09.2023 / End Date: 29.09.2023

More info: https://x2-0.eu/3rd-open-call-healthtech-biotech/

Do not hesitate to contact your EEN Health Advisor, Emilie Fonck for more information

News in the Category View all news

All IN : INternationalisation & INnovation to INcrease your INcome

Tailored and free support for SMEs on access to public funding, innovation management and internationalisation In today’s competitive and complex business landscape, small and medium-sized enterprises (SMEs) often find themselves facing numerous challenges when it comes to accessing funding, making the most out of their innovation potential, and expanding internationally. These hurdles can sometimes hinder […]

New funding opportunity for innovative products and services in zero emission vehicles

What are the E-BOOST Open Calls? E-BOOST is a Eurocluster co-funded by the European Commission under the SMP. It organises Open Calls with the overall aim to identify product innovations in order to reduce dependency on critical inputs and technologies in the E- BOOST value chains, to introduce new-to-firm products or services, and to engage […]

CBAM: Carbon Border Adjustment Mechanism

The Carbon Border Adjustment Mechanism (CBAM) is the EU’s instrument to set a fair price on carbon emitted when producing carbon-intensive goods

Start typing and press Enter to search